Showing results (801-810 of 2,241) with videos related to
Sort By:
Pageof 225
Current Neuropharmacology|July 11, 2008
Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategiesP Bonsi, D Cuomo, G Martella, et al.Infection|October 19, 2020
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literatureMarianna Meschiari, Iacopo Franconi, Erica Bacca, et al.Clinical Microbiology Reviews|October 4, 2014
Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environmentTim K Mackey, Bryan A Liang, Raphael Cuomo, et al.Nucleic Acids Research|October 6, 2017
Chromatin proteomics reveals novel combinatorial histone modification signatures that mark distinct subpopulations of macrophage enhancersMonica Soldi, Tommaso Mari, Luciano Nicosia, et al.Plos One|November 16, 2013
The antiepileptic drug levetiracetam suppresses non-convulsive seizure activity and reduces ischemic brain damage in rats subjected to permanent middle cerebral artery occlusionOrnella Cuomo, Vincenzo Rispoli, Antonio Leo, et al.Bone Marrow Transplantation|June 18, 1998
Hematopoietic stem cells from different sources: biological and technical aspectsF Bertolini, M Battaglia, A Lanza, et al.Allergologia Et Immunopathologia|August 3, 2016
Matrix effect on baked milk tolerance in children with IgE cow milk allergyS Miceli Sopo, M Greco, S Monaco, et al.Journal of Clinical Medicine|June 13, 2025
Atypical Mycobacterium ulcerans Infection with Skip Lesions in a 68-Year-Old Male: A Rare Case and Comprehensive Literature ReviewRoberto Cuomo, Ishith Seth, Gianluca Marcaccini, et al.Journal of Clinical Medicine|April 13, 2024
Augmentation Rhinoplasty and Centrofacial Lipofilling: Our Experience (ARCL)Mirco Pozzi, Pietro Susini, Davide di Seclì, et al.The Oncologist|April 30, 2024
Association of opioid use with survival in patients with cancer treated with immune checkpoint inhibitors: it is time for evidence-based behaviorsRaffaele Giusti, Giampiero Porzio, Marco Maltoni, et al.Pageof 225